Evidence map›Paper›PMID 30479740›Full record

ReviewTherapeutic advances in drug safety2018

Strategies to promote public engagement around deprescribing.

Justin P Turner, Janet Currie, Johanna Trimble, Cara Tannenbaum

Open access · bronzeAbstract readReview
In one paragraph

Review in Therapeutic advances in drug safety, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
1.1field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 32 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Practical Incorporation of Stakeholder-Informed Ethics into Research Funding Decisions.Progress in community health partnerships : research, education, and action · 2024
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Deprescribing practices in Canada: A scoping review.Canadian pharmacists journal : CPJ = Revue des pharmaciens du Canada : RPC
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 1 country.

Justin P TurnerCentre de recherche Institut universitaire de gériatrie de Montréal 4545 chemin Queen Mary, Montreal, CANADA, H3W 1W4.ORCID https://orcid.org/0000-0003-0613-108X
Janet CurrieInterdisciplinary Studies Graduate Program and Applied Science/School of Nursing, University of British Columbia, British Columbia, Canada.
Johanna TrimblePatients for Patient Safety Canada, BC Patient Voices Network, Community Engagement Advisory Network (Vancouver Coastal Health Authority), British Columbia, Canada.
Cara TannenbaumFacultés de Médecine et de Pharmacie, Université de Montréal; Research Center of Institut Universitaire de Gériatrie de Montréal, Québec, Canada.
Institut Universitaire de Gériatrie de Montréal · CAUniversity of British Columbia · CAVancouver Coastal Health · CA

Funding

Scientific and Technical Computing CoreP2CHD047879 · NICHD · PRINCETON UNIVERSITY · PI SALGANIK, MATTHEW J. · 2014 to 2018
$2.0M
NICHD NIH HHS P2C HD047879
6 · The paper itself

Abstract

Many seniors remain unaware that certain medications may be harmful, despite high rates of polypharmacy and inappropriate medication use among community-dwelling older adults. Patient education is an effective method for reducing the use of inappropriate medications. Increasing public awareness and engagement is essential for promoting shared decision-making to deprescribe. The Canadian Deprescribing Network was created to address the lack of a systematic pan-Canadian initiative to implement deprescribing among older Canadians. The Canadian Deprescribing Network deliberately included patient advocates in its organization from the outset, in order to ensure a key strategic focus on public awareness and education. In this paper, we present the processes and activities rolled out by the Canadian Deprescribing Network as a blueprint model for engaging the public on deprescribing. Embedded within the structure of the network, the subcommittee on public awareness and engagement implements an action plan that includes needs assessments, population surveys, focus groups, deprescribing fairs, national stakeholders' meetings, public lectures and monthly exchanges with community champions and seniors' organizations. Educational materials and online media have been developed based on the answers to the questions: what information do seniors need about deprescribing? who should this information be delivered to? who needs to deliver the message? and how should seniors be engaged in deprescribing? In conjunction with seniors' organizations, members of the Network have iteratively refined key deprescribing messages, disseminated information about deprescribing, engaged the press and created a grass roots-driven public awareness and education campaign across Canada. Over 3000 seniors and seniors' organizations are involved, with over 25,000 educational tools being distributed across the country.

Indexed as

agedcommunity participationconsumer advocacydeprescribingeducationpublic health professional

Identifiers

PMID30479740
PMCPMC6243424
OpenAlexW2891540702

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.